Iron metabolism: From health to disease

Journal of Clinical Laboratory Analysis

Volumn 28, Issue 3, 2014, Pages 210-218

  Oliveira, Fernando ^a   Rocha, Sara ^a   Fernandes, Rúben ^a,b  

^a POLYTECHNIC INSTITUTE OF PORTO   (Portugal)

^b University of Porto   (Portugal)

Author keywords

Homeostasis; Iron; Iron deficiency; Iron overload; Toxicity

Indexed keywords

FERROPORTIN 1; HEMOGLOBIN; IRON; IRON BINDING PROTEIN; LACTOFERRIN; SIDEROCALIN; TRANSFERRIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL INFECTION; BLEEDING; BLOOD DONOR; CHRONIC LIVER DISEASE; DUODENUM; ERYTHROPOIESIS; GASTROINTESTINAL HEMORRHAGE; GROWTH RATE; HOMEOSTASIS; HUMAN; IRON ABSORPTION; IRON DEFICIENCY; IRON DEFICIENCY ANEMIA; IRON DEPLETION; IRON HOMEOSTASIS; IRON INTAKE; IRON METABOLISM; IRON OVERLOAD; IRON STORAGE; IRON TRANSPORT; JEJUNUM; LACTATION; MALABSORPTION; MENSTRUATION; NONHUMAN; OXIDATIVE STRESS; PREGNANCY; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SMALL INTESTINE ABSORPTION; TISSUE DISTRIBUTION; TISSUE INJURY; TRANSFERRIN BLOOD LEVEL; IRON METABOLISM DISORDER; METABOLISM; PATHOLOGY;

HOMEOSTASIS; HUMANS; IRON; IRON METABOLISM DISORDERS;

EID: 84899549450     PISSN: 08878013     EISSN: 10982825     Source Type: Journal    
DOI: 10.1002/jcla.21668     Document Type: Article

References (77)

1. Arredondo M, Nunez MT. Iron and copper metabolism. Mol Asp Med 2005;26(4-5):313-327.
2. Lieu PT, Heiskala M, Peterson PA, Yang Y. The roles of iron in health and disease. Mol Asp Med 2001;22(1-2):1-87.
3. Papanikolaou G, Pantopoulos K. Iron metabolism and toxicity. Toxicol Appl Pharmacol 2005;202(2):199-211.
4. Verga Falzacappa MV, Muckenthaler MU. Hepcidin: Iron-hormone and anti-microbial peptide. Gene 2005;364:37-44.
5. Skaar EP. The battle for iron between bacterial pathogens and their vertebrate hosts. PLoS Pathog 2010;6(8):e1000949.
6. Bartnikas TB, Fleming MD, Schmidt PJ. Murine mutants in the study of systemic iron metabolism and its disorders: An update on recent advances. Biochim Biophys Acta 2012;1823(9):1444-1450.
7. Gkouvatsos K, Papanikolaou G, Pantopoulos K. Regulation of iron transport and the role of transferrin. Biochim Biophys Acta 2012;1820(3):188-202.
8. Knovich MA, Storey JA, Coffman LG, Torti SV, Torti FM. Ferritin for the clinician. Blood Rev 2009;23(3):95-104.
9. O'Brien TX. Iron metabolism, anemia, and heart failure. J Am Coll Cardiol 2011;58(12):1252-1253.
10. Chemmanur AT, Bonkovsky HL. Hepatic porphyrias: Diagnosis and management. Clin Liver Dis 2004;8(4):807-38, viii.
11. Ye H, Rouault TA. Human iron-sulfur cluster assembly, cellular iron homeostasis, and disease. Biochemistry 2010;49(24):4945-4956.
12. Peyssonnaux C, Nizet V, Johnson RS. Role of the hypoxia inducible factors HIF in iron metabolism. Cell Cycle 2008;7(1):28-32.
13. Bruick RK. Oxygen sensing in the hypoxic response pathway: Regulation of the hypoxia-inducible transcription factor. Genes Dev 2003;17(21):2614-2623.
14. Dery MA, Michaud MD, Richard DE. Hypoxia-inducible factor 1: Regulation by hypoxic and non-hypoxic activators. Int J Biochem Cell Biol 2005;37(3):535-540.
15. Camaschella C, Strati P. Recent advances in iron metabolism and related disorders. Intern Emerg Med 2010;5(5):393-400.
16. Muñoz M, Garcí-Erce JA, Remacha ÁF. Disorders of iron metabolism. Part 1: Molecular basis of iron homoeostasis. J Clin Pathol 2011;64:281-286.
17. Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev 2006;27(1):5-16.
18. Muñoz M, Villar I, García-Erce JA. An update on iron physiology. World Gastroenterol 2009;15(37):4617-4626.
19. Andrews NC, Schmidt PJ. Iron homeostasis. Annu Rev Physiol 2007;69:69-85.
20. Garrick MD, Singleton ST, Vargas F, et al. DMT1: Which metals does it transport. Biol Res 2006;39:79-85.
21. Shayeghi M, Latunde-Dada GO, Oakhill JS, et al. Identification of an intestinal heme transporter. Cell 2005;122:789-801.
22. Andrews NC. Understanding heme transport. New Engl J Med 2005;353(23):2508-2509.
23. Muñoz M, García-Erce JA, Remacha ÁF. Disorders of iron metabolism. Part II: Iron deficiency and iron overload. J Clin Pathol 2011;64:287-296.
24. Muckenthaler M, Richter A, Gunkel N, et al. Relationships and distinctions in iron-regulatory networks responding to interrelated signals. Blood 2003;101(9):3690-3698.
25. Ramey G, Deschemin J-C, Durel B, Canonne-Hergaux F, Nicolas G, Vaulont S. Hepcidin targets ferroportin for degradation in hepatocytes. Haematologica 2010;95(3):501-504.
26. Nemeth E, Ganz T. Hepcidin and iron-loading anemias. Haematologica 2006;91(6):727-732.
27. Siah CW, Ombiga J, Adams LA, Trinder D, Olynyk JK. Normal iron metabolism and the pathophysiology of iron overload disorders. Clin Biochem Rev 2006;27:5-16.
28. Kehl-Fie TE, Skaar EP. Nutritional immunity beyond iron: A role for manganese and zinc. Curr Opin Chem Biol 2010;14(2):218-224.
29. Sritharan M. Iron and bacterial virulence. Indian J Med Microbiol 2006;24(3):163-164.
30. Ward PP, Conneely OM. Lactoferrin: Role in iron homeostasis and host defense against microbial infection. Biometals 2004;17(3):203-208.
31. Arnold RR, Russell JE, Champion WJ, Brewer M, Gauthier JJ. Bactericidal activity of human lactoferrin: Differentiation from the stasis of iron deprivation. Infect Immun 1982;35(3):792-799.
32. Farnaud S, Evans RW. Lactoferrin-A multifunctional protein with antimicrobial properties. Mol Immunol 2003;40(7):395-405.
33. Yamauchi K, Tomita M, Giehl TJ, Ellison RT, 3rd. Antibacterial activity of lactoferrin and a pepsin-derived lactoferrin peptide fragment. Infect Immun 1993;61(2):719-728.
34. Valenti P, Antonini G. Lactoferrin: An important host defence against microbial and viral attack. Cell Mol Life Sci 2005;62(22):2576-2587.
35. Bao G, Clifton M, Hoette TM, et al. Iron traffics in circulation bound to a siderocalin (Ngal)-catechol complex. Nat Chem Biol 2010;6(8):602-609.
36. Flo TH, Smith KD, Sato S, et al. Lipocalin 2 mediates an innate immune response to bacterial infection by sequestrating iron. Nature 2004;432(7019):917-921.
37. Goetz DH, Holmes MA, Borregaard N, Bluhm ME, Raymond KN, Strong RK. The neutrophil lipocalin NGAL is a bacteriostatic agent that interferes with siderophore-mediated iron acquisition. Mol Cell 2002;10(5):1033-1043.
38. Crichton RR, Wilmet S, Legssyer R, Ward RJ. Molecular and cellular mechanisms of iron homeostasis and toxicity in mammalian cells. J Inorg Biochem 2002;91(1):9-18.
39. Loh A, Hadziahmetovic M, Dunaief JL. Iron homeostasis and eye disease. Biochim Biophys Acta 2009;1790(7):637-649.
40. Cairo G, Recalcati S, Pietrangelo A, Minotti G. The iron regulatory proteins: Targets and modulators of free radical reactions and oxidative damage. Free Radic Biol Med 2002;32(12):1237-1243.
41. Puntarulo S. Iron, oxidative stress and human health. Mol Asp Med 2005;26(4-5):299-312.
42. Comporti M, Signorini C, Buonocore G, Ciccoli L. Iron release, oxidative stress and erythrocyte ageing. Free Radic Biol Med 2002;32(7):568-576.
43. Jones DP. Radical-free biology of oxidative stress. Am J Physiol Cell Physiol 2008;295(4):C849-C868.
44. Bresgen N, Jaksch H, Lacher H, Ohlenschlager I, Uchida K, Eckl PM. Iron-mediated oxidative stress plays an essential role in ferritin-induced cell death. Free Radic Biol Med 2010;48(10):1347-1357.
45. Levenson CW, Tassabehji NM. Iron and ageing: An introduction to iron regulatory mechanisms. Ageing Res Rev 2004;3(3):251-263.
46. Mendes JF, Arruda SF, Siqueira EM, Ito MK, Silva EF. Iron status and oxidative stress biomarkers in adults: A preliminary study. Nutrition 2009;25(4):379-384.
47. Petersen DR. Alcohol, iron-associated oxidative stress, and cancer. Alcohol 2005;35(3):243-249.
48. Polla AS, Polla LL, Polla BS. Iron as the malignant spirit in successful ageing. Ageing Res Rev 2003;2(1):25-37.
49. Yu S, Feng Y, Shen Z, Li M. Diet supplementation with iron augments brain oxidative stress status in a rat model of psychological stress. Nutrition 2011;27(10):1048-1052.
50. Smith MA, Zhu X, Tabaton M, et al. Increased iron and free radical generation in preclinical Alzheimer disease and mild cognitive impairment. J Alzheimer's Dis 2010;19(1):363-372.
51. Cook JD. Diagnosis and management of iron-deficiency anaemia. Best Pract Res Clin Haematol 2005;18(2):319-332.
52. Suominen P, Punnonen K, Rajamaki A, Irjala K. Serum transferrin receptor and transferrin receptor-ferritin index identify healthy subjects with subclinical iron deficits. Blood 1998;92(8):2934-2939.
53. Punnonen K, Irjala K, Rajamaki A. Iron-deficiency anemia is associated with high concentrations of transferrin receptor in serum. Clin Chem 1994;40(5):774-776.
54. Bermejo F, Garcia-Lopez S. A guide to diagnosis of iron deficiency and iron deficiency anemia in digestive diseases. World J Gastroenterol 2009;15(37):4638-4643.
55. Schmidt AT, Alvarez GC, Grove WM, Rao R, Georgieff MK. Early iron deficiency enhances stimulus-response learning of adult rats in the context of competing spatial information. Dev Cogn Neurosci 2012;2(1):174-180.
56. Sachdev H, Gera T, Nestel P. Effect of iron supplementation on mental and motor development in children: Systematic review of randomised controlled trials. Public Health Nutr 2005;8(2):117-132.
57. Murray-Kolb LE, Beard JL. Iron treatment normalizes cognitive functioning in young women. Am J Clin Nutr 2007;85(3):778-787.
58. Allen LH. Anemia and iron deficiency: Effects on pregnancy outcome. Am J Clin Nutr 2000;71(5 Suppl):1280S-1284S.
59. Aslan M, Horoz M, Kocyigit A, et al. Lymphocyte DNA damage and oxidative stress in patients with iron deficiency anemia. Mutat Res 2006;601(1-2):144-149.
60. Yoo JH, Maeng HY, Sun YK, et al. Oxidative status in iron-deficiency anemia. J Clin Lab Anal 2009;23(5):319-323.
61. Pra D, Rech Franke SI, Henriques JA, Fenech M. Iron and genome stability: An update. Mutat Res 2012;733(1-2):92-99.
62. Khan FA, Fisher MA, Khakoo RA. Association of hemochromatosis with infectious diseases: Expanding spectrum. Int J Infect Dis 2007;11(6):482-487.
63. Gomes-Pereira S, Rodrigues PN, Appelberg R, Gomes MS. Increased susceptibility to Mycobacterium avium in hemochromatosis protein HFE-deficient mice. Infect Immun 2008;76(10):4713-4719.
64. Gattermann N. The treatment of secondary hemochromatosis. Dtsch Arztebl Int 2009;106(30):499-504.
65. Chales G, Guggenbuhl P. When and how should we screen for hereditary hemochromatosis? Joint Bone Spine 2003;70(4):263-270.
66. Moyer TP, Highsmith WE, Smyrk TC, Gross JB, Jr. Hereditary hemochromatosis: Laboratory evaluation. Clin Chim Acta 2011;412(17-18):1485-1492.
67. Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13(4):399-408.
68. Lee PL, Beutler E. Regulation of hepcidin and iron-overload disease. Annu Rev Pathol 2009;4:489-515.
69. Bacon BR, Adams PC, Kowdley KV, Powell LW, Tavill AS. Diagnosis and management of hemochromatosis: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011;54(1):328-343.
70. Wallace DF, Subramaniam VN. Non-HFE haemochromatosis. World J Gastroenterol 2007;13(35):4690-4698.
71. Piperno A. Classification and diagnosis of iron overload. Haematologica 1998;83(5):447-455.
72. Gardenghi S, Marongiu MF, Ramos P, et al. Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin. Blood 2007;109(11):5027-5035.
73. Melchiori L, Gardenghi S, Rivella S. Beta-Thalassemia: HiJAKing ineffective erythropoiesis and iron overload. Adv Hematol 2010;2010:938640.
74. Ganz T, Nemeth E. Iron metabolism: Interactions with normal and disordered erythropoiesis. Cold Spring Harb Perspect Med 2012;2(5):a011668.
75. Gattermann N. Guidelines on iron chelation therapy in patients with myelodysplastic syndromes and transfusional iron overload. Leuk Res 2007;31(Suppl 3):S10-S15.
76. Goldberg SL. Novel treatment options for transfusional iron overload in patients with myelodysplastic syndromes. Leuk Res 2007; 31(Suppl 3):S16-S22.
77. Brittenham GM. Iron-chelating therapy for transfusional iron overload. N Engl J Med 2011;364(2):146-156.